Shamarlon Yates
About Shamarlon Yates
Shamarlon Yates is a Senior Manager of Business Strategy and Operations at Kite Pharma, where he has worked since 2023. He has a background in healthcare and pharmaceutical consulting, with previous roles at Accenture and dbaza Health.
Work at Kite Pharma
Shamarlon Yates currently serves as Senior Manager, Business Strategy & Operations at Kite Pharma, a position he has held since 2023. Prior to this role, he worked as Manager, Business Strategy & Operations at the same company from 2022 to 2023. His responsibilities include overseeing strategic initiatives and operational processes to enhance the company's performance in the biopharmaceutical sector. Kite Pharma is known for its focus on innovative cancer therapies, and Yates contributes to the organization’s mission through his expertise in business strategy.
Education and Expertise
Shamarlon Yates holds a Bachelor’s Degree in Philosophy, Politics, & Economics (PPE) from the University of Pennsylvania, where he graduated Magna Cum Laude in 2017. He completed his high school education at Science Leadership Academy from 2009 to 2013. His educational background provides him with a strong foundation in analytical thinking and strategic decision-making, which he applies in his current role in the biopharmaceutical industry.
Professional Background
Yates has a diverse professional background, primarily in the healthcare and pharmaceutical sectors. He began his career as a Healthcare Start-up Intern at dbaza Health in 2015. He then joined Accenture, where he held various roles, including Analyst, Strategy & Consulting Manager, and Management Consultant in Pharma Research & Development from 2017 to 2022. He also gained experience as a Research Assistant at the Leonard Davis Institute of Health Economics and as a Clinical Research Coordinator at the University of Pennsylvania Center for Health Incentives and Behavioral Economics.
Career Progression at Accenture
At Accenture, Shamarlon Yates progressed through several roles in Pharma Research & Development. He started as an Analyst in 2017 and moved up to Senior Analyst in 2018. He then served as a Management Consultant from 2019 to 2021 and later as Strategy & Consulting Manager from 2021 to 2022. His experience at Accenture equipped him with valuable insights into the pharmaceutical industry, enhancing his strategic and operational capabilities.